View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
PALOMA-3 - Lazertinib 240 / Amivantamab 3520, Non-Small Cell Lung Cancer, Cycle 2+
Protocol-ID: 3193 V1.0 (Mini), PALOMA-3 - LAZE240/AMIV3520, NSCLC, C2+Indication(s)
- Lung Carcinoma, Non-Small Cell; ICD-10 C34.-
EGFR exon 19 deletion mutation ● EGFR exon 21 Leu858Arg mutation
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. |
Valid since: 22.04.2026